Introduction
Diagnosis and treatment of metastatic and castration resistant prostate cancer became more and more and complex due to the increasing knowledge and understanding of the underlying molecular events and the subsequently deducted innovative medical treatment approaches.
Modern imaging studies in CRPCA have become more and more complex and selective and currently include positron emission tomography, whole body magnetic resonance imaging, immunoscintigraphy besides the traditional studies such as bone scans and computed tomography.
Articles
00558-X/assets/gr1/gr1_98x60.jpg)
01072-0/assets/gr2/gr2_98x60.jpg)
00214-X/assets/gr1/gr1_98x60.jpg)
About the Editor
Kurt Miller MD, PhD
Professor Miller has been Chairman and Professor of Urology for the Department of Urology at the Benjamin Franklin Medical Center, Berlin, Germany, since 1993. In 2007 he became Chairman of the ...
Read more »
Congress planner
2013
-
24 May - 25 May
6th Pomeranian Uro-Oncology Conference
Jastrzębia Góra, Poland
Contact: Elżbieta Senkus-Konefka –
Medical University of Gdańsk
Tel.: +48 58 3492221
Fax: +48 58 3492210
E-mail: elsenkus@gumed.edu.pl
Website: www.uro-onko.pl -
27 May - 1 June
38th Annual Meeting of the International Urogynecological Association
Dublin, Ireland
Contact: IUGA Offi ce
Tel.: +1 954 933 1728
Fax: +1 954 933 1648
E-mail: offi ce@iuga.org
Website: www.iuga.org -
29 May - 31 May
6th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer
Amsterdam-Noordwijk, The Netherlands
Contact: Erasmus SA
Tel.: +30 210 7414700
Fax: +30 210 7257532
E-mail: info@focaltherapy.org
Website: www.focaltherapy.org
